Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Leukemia 21Lymphoma 7Burkitt Lymphoma 6Leukemia, Myeloid, Acute 5Leukemia, Biphenotypic, Acute 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Anemia, Refractory, with Excess of Blasts 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Myeloproliferative Disorders 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Down Syndrome 2Anemia, Refractory 2Sarcoma, Myeloid 1Recurrence 1Neoplasms 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Basophilic, Acute 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Cardiotoxicity 1

Interventions

Radiotherapy 3Pyridoxine 2Etoposide 2Epoetin Alfa 2Cisplatin 2Capecitabine 2uridine triacetate 1peginterferon alfa-2b 1pegaspargase 1Vincristine 1Pyridostigmine Bromide 1Prednisolone 1Paclitaxel 1Oxaliplatin 1Octreotide 1Methylprednisolone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Laparoscopy 1Introns 1Hydrocortisone 1Gemcitabine 1Furosemide 1Fluorouracil 1Filgrastim 1Erythropoietin 1Duloxetine Hydrochloride 1Doxorubicin 1Dexrazoxane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Drug-Related Side Effects and Adverse Reactions × Asparaginase × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡